These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 8627184
1. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. Stuber E, Strober W, Neurath M. J Exp Med; 1996 Feb 01; 183(2):693-8. PubMed ID: 8627184 [Abstract] [Full Text] [Related]
2. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Kelsall BL, Stüber E, Neurath M, Strober W. Ann N Y Acad Sci; 1996 Oct 31; 795():116-26. PubMed ID: 8958922 [Abstract] [Full Text] [Related]
3. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-beta1 plasmid: TGF-beta1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor beta2 chain downregulation. Kitani A, Fuss IJ, Nakamura K, Schwartz OM, Usui T, Strober W. J Exp Med; 2000 Jul 03; 192(1):41-52. PubMed ID: 10880525 [Abstract] [Full Text] [Related]
4. Antibodies to interleukin 12 abrogate established experimental colitis in mice. Neurath MF, Fuss I, Kelsall BL, Stüber E, Strober W. J Exp Med; 1995 Nov 01; 182(5):1281-90. PubMed ID: 7595199 [Abstract] [Full Text] [Related]
5. Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis. Boirivant M, Fuss IJ, Ferroni L, De Pascale M, Strober W. J Immunol; 2001 Mar 01; 166(5):3522-32. PubMed ID: 11207312 [Abstract] [Full Text] [Related]
6. Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells. Ria F, Penna G, Adorini L. Eur J Immunol; 1998 Jun 01; 28(6):2003-16. PubMed ID: 9645382 [Abstract] [Full Text] [Related]
7. Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Carayanniotis G, Masters SR, Noelle RJ. Immunology; 1997 Mar 01; 90(3):421-6. PubMed ID: 9155650 [Abstract] [Full Text] [Related]
8. Accessory signaling by CD40 for T cell activation: induction of Th1 and Th2 cytokines and synergy with interleukin-12 for interferon-gamma production. Peng X, Kasran A, Warmerdam PA, de Boer M, Ceuppens JL. Eur J Immunol; 1996 Jul 01; 26(7):1621-7. PubMed ID: 8766570 [Abstract] [Full Text] [Related]
9. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD154 administration. De Jong YP, Comiskey M, Kalled SL, Mizoguchi E, Flavell RA, Bhan AK, Terhorst C. Gastroenterology; 2000 Sep 01; 119(3):715-23. PubMed ID: 10982766 [Abstract] [Full Text] [Related]
10. Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity. Tang A, Judge TA, Turka LA. Eur J Immunol; 1997 Dec 01; 27(12):3143-50. PubMed ID: 9464799 [Abstract] [Full Text] [Related]
11. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice. Tozawa K, Hanai H, Sugimoto K, Baba S, Sugimura H, Aoshi T, Uchijima M, Nagata T, Koide Y. J Gastroenterol Hepatol; 2003 May 01; 18(5):578-87. PubMed ID: 12702051 [Abstract] [Full Text] [Related]
12. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. Van den Eertwegh AJ, Noelle RJ, Roy M, Shepherd DM, Aruffo A, Ledbetter JA, Boersma WJ, Claassen E. J Exp Med; 1993 Nov 01; 178(5):1555-65. PubMed ID: 7693849 [Abstract] [Full Text] [Related]
13. Prevention of experimental colitis in SCID mice reconstituted with CD45RBhigh CD4+ T cells by blocking the CD40-CD154 interactions. Liu Z, Geboes K, Colpaert S, Overbergh L, Mathieu C, Heremans H, de Boer M, Boon L, D'Haens G, Rutgeerts P, Ceuppens JL. J Immunol; 2000 Jun 01; 164(11):6005-14. PubMed ID: 10820284 [Abstract] [Full Text] [Related]
14. Experimental granulomatous colitis in mice is abrogated by induction of TGF-beta-mediated oral tolerance. Neurath MF, Fuss I, Kelsall BL, Presky DH, Waegell W, Strober W. J Exp Med; 1996 Jun 01; 183(6):2605-16. PubMed ID: 8676081 [Abstract] [Full Text] [Related]
15. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Kennedy MK, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, Chin WA, Mohler KM. Eur J Immunol; 1996 Feb 01; 26(2):370-8. PubMed ID: 8617306 [Abstract] [Full Text] [Related]
16. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Fuss IJ, Marth T, Neurath MF, Pearlstein GR, Jain A, Strober W. Gastroenterology; 1999 Nov 01; 117(5):1078-88. PubMed ID: 10535870 [Abstract] [Full Text] [Related]
17. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer. Subauste CS, Wessendarp M, Sorensen RU, Leiva LE. J Immunol; 1999 Jun 01; 162(11):6690-700. PubMed ID: 10352287 [Abstract] [Full Text] [Related]
18. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice. Resetkova E, Kawai K, Enomoto T, Arreaza G, Togun R, Foy TM, Noelle RJ, Volpé R. Thyroid; 1996 Aug 01; 6(4):267-73. PubMed ID: 8875745 [Abstract] [Full Text] [Related]
19. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses. Dohi T, Fujihashi K, Rennert PD, Iwatani K, Kiyono H, McGhee JR. J Exp Med; 1999 Apr 19; 189(8):1169-80. PubMed ID: 10209035 [Abstract] [Full Text] [Related]
20. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. Foy TM, Shepherd DM, Durie FH, Aruffo A, Ledbetter JA, Noelle RJ. J Exp Med; 1993 Nov 01; 178(5):1567-75. PubMed ID: 7693850 [Abstract] [Full Text] [Related] Page: [Next] [New Search]